Medical Researcher Did Not Have Duty to Warn of Potential Rezulin Dangers, Judge Rules

NEW YORK - A medical researcher who conducted pre-clinical studies on Rezulin cannot be found liable for injuries allegedly caused by the drug because he did not have a duty to warn, a federal judge ruled in an order dismissing claims against the doctor in 27 product liability cases. In re: Rezulin Products Liability Litigation, MDL No. 1348 (S.D.N.Y.).

Dr. Jerrold Olefsky, an endocrinologist and diabetes researcher, owed no legal duty to the plaintiffs since he did not have any contact with the them or their treating physicians, U.S. District Judge Lewis A. Kaplan opined in an order entered May …